Results 51 to 60 of about 2,589,900 (302)
KDM7A and KDM1A inhibition suppresses tumour promoting pathways in prostate cancer
Molecular Oncology, EarlyView.Treatment resistance is a major challenge for patients with advanced prostate cancer. This study examined an alternative approach to target the major prostate cancer‐promoting pathway by targeting epigenetic factors, whose levels are higher in tumours.
Jennie N Jeyapalan +16 more
wiley +1 more source
Molecular Oncology, EarlyView.Intratumour heterogeneity complicates precision management of advanced endometrial cancer. Circulating tumor DNA (ctDNA) offers a minimally invasive strategy to capture tumor evolution and therapeutic resistance. Here, we compare tumor‐agnostic NGS with tumor‐informed ddPCR, outlining their relative sensitivity, concordance, and clinical implications ...
Carlos Casas‐Arozamena +15 more
wiley +1 more source
An examination of quantitative methods for Forensic Signature Analysis and the admissibility of signature verification system as legal evidence. [PDF]
, 2015 The experiments described in this thesis deal with handwriting characteristics which are involved in the production of forged and genuine signatures and complexity of signatures.
Chatzisterkotis, Thomas
core
Interpreting the effects of DNA polymerase variants at the structural level
Molecular Oncology, EarlyView.Using MAVISp and molecular dynamics simulations, we analyzed over 60 000 missense variants in POLE and POLD1 from ClinVar, COSMIC, cBioPortal, and saturation mutagenesis. Identified mechanistic indicators, including stability, binding, and long‐range, enable structural interpretation, providing ACMG‐like evidence for possible reclassification of VUS ...
Matteo Arnaudi +7 more
wiley +1 more source
Cryptanalysis of A New Multi-Proxy Multi-Signature Scheme
, 2009 [[abstract]]Recently, Hwang and Chen [5] proposed a variation of proxy signature scheme called the multi-proxy multi-signature scheme. In their scheme, an authorized group of proxy signers is allowed to sign message on behalf of a group of original ...
孫宏民;謝濱燦;林宸堂
core
Molecular Oncology, EarlyView.Radiotherapy (RT) response depends on the DNA repair capacity of tumor and host cells. We show that circulating tumor cell (CTC) counts and apoptosis rates before and after RT predict treatment response and outcome, which can be accessed via easily accessible liquid biopsy approaches. Created in BioRender. Wikman, H.
Yvonne Goy +10 more
wiley +1 more source
A Non-repudiable Multi-Proxy Multi-Signature Scheme
, 2012 [[abstract]]In this paper, we shall propose a threshold multi-proxy multi-signature scheme with shared verification. In the scheme allows the group of original signers to delegate the signing capability to the designated group of proxy signers ...
黃明祥;Hwang, Min-Shiang
core
Adaptive feature thresholding for off-line signature verification
, 2008 This paper introduces Adaptive Feature Thresholding (AFT) which is a novel method of person-dependent off-line signature verification. AFT enhances how a simple image feature of a signature is converted to a binary feature vector by significantly ...
Larkins, Robert L. +3 more
core +1 more source
An Improved RSA-based Certificateless Multi-signature Scheme
工程科学与技术, 2017 :Three forgery attacks on Liu Li et al.'s RSA-based certificateless multi-signature scheme were first presented.It could be found that their scheme was vulnerable to key replacement attacks.The scheme also could not resist conspiracy attack of dishonest ...
农强, 黄茹芬, 陈群山
doaj
Multi-signature based person re-identification
Electronics Letters, 2012 A novel appearance-based method for person re-identification is proposed. The approach exploits three local features to extract the shape and the chromatic appearance of an individual. Robustness against low resolution images, viewpoint and illumination changes, occlusions and pose variations is achieved by a novel signature.
MARTINEL, Niki, FORESTI, Gian Luca
openaire +2 more sources